Scientific article
English

Down syndrome: from understanding the neurobiology to therapy

Published in

The Journal of neuroscience, vol. 30, no. 45, p. 14943-14945

Publication date

2010

Abstract

Down syndrome (DS) is the most common example of a neurogenetic aneuploid disorder leading to mental retardation. In most cases, DS results from an extra copy of human chromosome 21 producing deregulated gene expression in brain that gives raise to subnormal intellectual functioning. Understanding the consequences of dosage imbalance attributable to trisomy 21 (T21) has accelerated because of recent advances in genome sequencing, comparative genome analysis, functional genome exploration, and the use of model organisms. This has led to new evidence-based therapeutic approaches to prevention or amelioration of T21 effects on brain structure and function (cognition) and has important implications for other areas of research on the neurogenomics of cognition and behavior.

Keywords

  • Animals
  • Disease Models, Animal
  • Down Syndrome/genetics/*physiopathology/*therapy
  • Humans
  • Intellectual Disability/genetics/*physiopathology

Citation (ISO format)

GARDINER, Katheleen et al. Down syndrome: from understanding the neurobiology to therapy. In: The Journal of neuroscience, 2010, vol. 30, n° 45, p. 14943–14945. doi: 10.1523/JNEUROSCI.3728-10.2010

Main files (1)

Article

Identifiers

Journal ISSN

0270-6474
723views
2downloads

Technical informations

Creation

23/05/2012 08:45:36

First validation

23/05/2012 08:45:36

Update

14/03/2023 17:33:11

Status update

14/03/2023 17:33:11

Last indexation

29/10/2024 20:00:41
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated